Key result
ST-segment elevation in leads V1-2 was independently associated with a higher risk for the composite of death or surgical aortic valve replacement in patients with severe aortic stenosis.
Why the study?
Does the presence of ST-segment elevation in leads V1-2 predict death or need for surgical aortic valve replacement in patients with severe aortic stenosis?
Cohort (n=211)
No
Does the presence of ST-segment elevation in leads V1-2 predict death or need for surgical aortic valve replacement in patients with severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
ST-segment elevation in leads V1-2 is a readily available ECG marker that independently predicts poorer prognosis and more frequent need for surgical aortic valve replacement in patients with severe aortic stenosis.
BACKGROUND: ST-segment elevation (STE) in leads V1-2 is often observed in patients with severe aortic stenosis (AS), but its significance remains unknown. METHODS AND RESULTS: We retrospectively evaluated baseline ECGs and 5-year clinical outcomes in 211 consecutive patients with severe AS, defined as peak aortic jet velocity (Aortic Vmax) >4.0 m/s, or mean aortic pressure gradient >40 mmHg, or aortic valve area (AVA) <1.0 cm(2). The primary outcome measure was a composite of death or surgical aortic valve replacement (AVR). Patients with STE in leads V1-2(≥0.15 mV) had greater Aortic Vmax and smaller AVA than patients without. With a median follow-up of 4.9 years, the cumulative 5-year incidence of death or AVR was significantly higher in patients with STE in leads V1-2 than in patients without (91.4% vs. 77.1%; P=0.003). After adjusting for confounders, STE in leads V1-2 was independently associated with higher risk for death or AVR (hazard ratio, 1.53; 95% confidence interval, 1.06-2.22; P=0.02). In 64 asymptomatic patients without any indication for AVR at initial diagnosis of severe AS, the cumulative incidence of AVR was significantly higher in patients with STE in leads V1-2 than in patients without (57.6% vs. 30.5%; P<0.001). CONCLUSIONS: STE in leads V1-2 independently predicted poorer prognosis and more frequent need for AVR in patients with severe AS.
No takes yet. Share an insight, caveat, or question.
Taniguchi et al. (2016) conducted a cohort in Severe aortic stenosis (n=211). ST-segment elevation in leads V1-2 vs. No ST-segment elevation in leads V1-2 was evaluated on Composite of death or surgical aortic valve replacement (AVR) (HR 1.53, 95% CI 1.06-2.22, p=0.02). ST-segment elevation in leads V1-2 was independently associated with a higher risk for the composite of death or surgical aortic valve replacement in patients with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: